vs

Side-by-side financial comparison of MODINE MANUFACTURING CO (MOD) and Moderna (MRNA). Click either name above to swap in a different company.

Moderna is the larger business by last-quarter revenue ($1.0B vs $805.0M, roughly 1.3× MODINE MANUFACTURING CO). MODINE MANUFACTURING CO runs the higher net margin — -5.9% vs -19.7%, a 13.8% gap on every dollar of revenue. On growth, MODINE MANUFACTURING CO posted the faster year-over-year revenue change (30.5% vs -45.4%). MODINE MANUFACTURING CO produced more free cash flow last quarter ($-17.1M vs $-880.0M). Over the past eight quarters, MODINE MANUFACTURING CO's revenue compounded faster (15.5% CAGR vs -45.0%).

Modine Manufacturing is a thermal management company established in 1916 in the United States. The company started as Modine Manufacturing Company by Arthur B Modine who patented the Spirex radiator for tractors. The Modine company manufactured the Turbotube radiator for Ford Model T cars. The company built the world's first vehicular wind tunnel in Racine, Wisconsin in 1941. During WWII, Modine manufactured aftercoolers for the P-51 Mustang fighter plane. After WWII, Modine introduced the Ai...

Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".

MOD vs MRNA — Head-to-Head

Bigger by revenue
MRNA
MRNA
1.3× larger
MRNA
$1.0B
$805.0M
MOD
Growing faster (revenue YoY)
MOD
MOD
+75.9% gap
MOD
30.5%
-45.4%
MRNA
Higher net margin
MOD
MOD
13.8% more per $
MOD
-5.9%
-19.7%
MRNA
More free cash flow
MOD
MOD
$862.9M more FCF
MOD
$-17.1M
$-880.0M
MRNA
Faster 2-yr revenue CAGR
MOD
MOD
Annualised
MOD
15.5%
-45.0%
MRNA

Income Statement — Q3 FY2026 vs Q3 FY2025

Metric
MOD
MOD
MRNA
MRNA
Revenue
$805.0M
$1.0B
Net Profit
$-47.4M
$-200.0M
Gross Margin
23.1%
79.6%
Operating Margin
11.1%
-25.6%
Net Margin
-5.9%
-19.7%
Revenue YoY
30.5%
-45.4%
Net Profit YoY
-215.6%
-1638.5%
EPS (diluted)
$-0.90
$-0.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MOD
MOD
MRNA
MRNA
Q4 25
$805.0M
Q3 25
$738.9M
$1.0B
Q2 25
$682.8M
Q1 25
$647.2M
Q4 24
$616.8M
$966.0M
Q3 24
$658.0M
$1.9B
Q2 24
$661.5M
Q1 24
$603.5M
Net Profit
MOD
MOD
MRNA
MRNA
Q4 25
$-47.4M
Q3 25
$44.4M
$-200.0M
Q2 25
$51.2M
Q1 25
$49.6M
Q4 24
$41.0M
$-1.1B
Q3 24
$46.1M
$13.0M
Q2 24
$47.3M
Q1 24
$25.8M
Gross Margin
MOD
MOD
MRNA
MRNA
Q4 25
23.1%
Q3 25
22.3%
79.6%
Q2 25
24.2%
Q1 25
25.6%
Q4 24
24.3%
23.5%
Q3 24
25.2%
72.4%
Q2 24
24.6%
Q1 24
22.4%
Operating Margin
MOD
MOD
MRNA
MRNA
Q4 25
11.1%
Q3 25
9.9%
-25.6%
Q2 25
11.1%
Q1 25
11.5%
Q4 24
9.6%
-129.0%
Q3 24
11.4%
-3.8%
Q2 24
11.2%
Q1 24
7.8%
Net Margin
MOD
MOD
MRNA
MRNA
Q4 25
-5.9%
Q3 25
6.0%
-19.7%
Q2 25
7.5%
Q1 25
7.7%
Q4 24
6.6%
-115.9%
Q3 24
7.0%
0.7%
Q2 24
7.2%
Q1 24
4.3%
EPS (diluted)
MOD
MOD
MRNA
MRNA
Q4 25
$-0.90
Q3 25
$0.83
$-0.51
Q2 25
$0.95
Q1 25
$0.92
Q4 24
$0.76
$-2.91
Q3 24
$0.86
$0.03
Q2 24
$0.88
Q1 24
$0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MOD
MOD
MRNA
MRNA
Cash + ST InvestmentsLiquidity on hand
$98.7M
$1.1B
Total DebtLower is stronger
$570.7M
Stockholders' EquityBook value
$1.1B
$9.3B
Total Assets
$2.5B
$12.1B
Debt / EquityLower = less leverage
0.51×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MOD
MOD
MRNA
MRNA
Q4 25
$98.7M
Q3 25
$83.8M
$1.1B
Q2 25
$124.5M
Q1 25
$71.6M
Q4 24
$83.8M
$1.9B
Q3 24
$78.6M
$1.6B
Q2 24
$72.9M
Q1 24
$60.1M
Total Debt
MOD
MOD
MRNA
MRNA
Q4 25
$570.7M
Q3 25
$525.8M
Q2 25
$482.1M
Q1 25
$296.7M
Q4 24
$330.0M
Q3 24
$359.1M
Q2 24
$405.7M
Q1 24
$399.9M
Stockholders' Equity
MOD
MOD
MRNA
MRNA
Q4 25
$1.1B
Q3 25
$1.1B
$9.3B
Q2 25
$1.0B
Q1 25
$910.2M
Q4 24
$855.1M
$10.9B
Q3 24
$858.8M
$11.9B
Q2 24
$788.4M
Q1 24
$747.6M
Total Assets
MOD
MOD
MRNA
MRNA
Q4 25
$2.5B
Q3 25
$2.4B
$12.1B
Q2 25
$2.2B
Q1 25
$1.9B
Q4 24
$1.8B
$14.1B
Q3 24
$1.9B
$15.8B
Q2 24
$1.9B
Q1 24
$1.9B
Debt / Equity
MOD
MOD
MRNA
MRNA
Q4 25
0.51×
Q3 25
0.50×
Q2 25
0.48×
Q1 25
0.33×
Q4 24
0.39×
Q3 24
0.42×
Q2 24
0.51×
Q1 24
0.53×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MOD
MOD
MRNA
MRNA
Operating Cash FlowLast quarter
$24.7M
$-847.0M
Free Cash FlowOCF − Capex
$-17.1M
$-880.0M
FCF MarginFCF / Revenue
-2.1%
-86.6%
Capex IntensityCapex / Revenue
5.2%
3.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-20.3M
$-1.9B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MOD
MOD
MRNA
MRNA
Q4 25
$24.7M
Q3 25
$1.4M
$-847.0M
Q2 25
$27.7M
Q1 25
$54.8M
Q4 24
$60.7M
$825.0M
Q3 24
$57.3M
$-1.6B
Q2 24
$40.5M
Q1 24
$39.6M
Free Cash Flow
MOD
MOD
MRNA
MRNA
Q4 25
$-17.1M
Q3 25
$-30.5M
$-880.0M
Q2 25
$200.0K
Q1 25
$27.1M
Q4 24
$44.7M
$303.0M
Q3 24
$43.8M
$-1.7B
Q2 24
$13.7M
Q1 24
$-4.3M
FCF Margin
MOD
MOD
MRNA
MRNA
Q4 25
-2.1%
Q3 25
-4.1%
-86.6%
Q2 25
0.0%
Q1 25
4.2%
Q4 24
7.2%
31.4%
Q3 24
6.7%
-92.2%
Q2 24
2.1%
Q1 24
-0.7%
Capex Intensity
MOD
MOD
MRNA
MRNA
Q4 25
5.2%
Q3 25
4.3%
3.2%
Q2 25
4.0%
Q1 25
4.3%
Q4 24
2.6%
54.0%
Q3 24
2.1%
8.1%
Q2 24
4.1%
Q1 24
7.3%
Cash Conversion
MOD
MOD
MRNA
MRNA
Q4 25
Q3 25
0.03×
Q2 25
0.54×
Q1 25
1.10×
Q4 24
1.48×
Q3 24
1.24×
-120.46×
Q2 24
0.86×
Q1 24
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MOD
MOD

Data Centers$296.9M37%
Performance Technologies$266.0M33%
Hvac Technologies$107.1M13%
Air Cooled$92.4M11%
Lb White$25.6M3%
Climate By Design$10.2M1%
Absolutaire$7.0M1%

MRNA
MRNA

COVID19$971.0M96%
Other Revenue$20.0M2%
Grant$14.0M1%
Collaboration Arrangement Including Arrangements With Affiliate$7.0M1%
License And Royalty$2.0M0%

Related Comparisons